You are here

Rapivab

After Falling 21% in a Month, Is There Any Hope for BioCryst Pharmaceuticals?

Motley Fool

Tue, 04/19/22 - 11:00 am

BioCryst Hits Trifecta For Flu, Ebola, and Hereditary Angioedema

Forbes

Fri, 12/26/14 - 10:22 pm

hereditary angiodema

From penny-stock fears to first-of-kind flu treatment: The story of Rapivab

Bizjournals.com

Tue, 12/23/14 - 09:13 am

FDA approves BioCryst's intravenous flu drug

Yahoo/Reuters

Mon, 12/22/14 - 09:28 am

The FDA May Find Some Use For Rapivab And Approve The Influenza Antiviral

Seeking Alpha

Thu, 12/18/14 - 04:09 pm

Single-Dose Flu Drug Shows Promise in Trials

Drug Discovery and Development

Mon, 09/8/14 - 09:40 pm

BioCryst Announces RAPIVAB(TM) Trial Results for the Treatment of Influenza at the ICAAC 2014 Meeting

Yahoo/Globe NewsWire

Sun, 09/7/14 - 10:44 am